Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Psyence Biomedical
(NASDAQ:PBM)
Intraday
$0.8964
0.0217
[2.48%]
After-Hours
$0.8964
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$0.8964
0.0217
[2.48%]
At close: May 21
$0.8964
0
[0.00%]
PreMarket: 12:33AM EDT
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Psyence Biomedical Stock (NASDAQ:PBM)
Psyence Biomedical Stock (NASDAQ: PBM)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, May 14, 2024
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
-
6 days ago
Wednesday, May 01, 2024
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
-
May 1, 2024, 4:31PM
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
-
May 1, 2024, 12:31PM
Wednesday, April 17, 2024
Psychedelics Headlines: Dementia Prevention, Psychological Flexibility, Ancient Romans' Trips And More
Lara Goldstein
-
Apr 17, 2024, 9:13AM
Psyence Biomed Announces Phase IIb Clinical Trial Listing On The Australian New Zealand Clinical Trials Registry
Benzinga Newsdesk
-
Apr 17, 2024, 8:01AM
Monday, April 08, 2024
Psyence Biomed Australian Subsidiary, Psyence Australia Partners With Fluence And iNGENū CRO To Train Research Therapists For Phase IIb Psilocybin Trial
Benzinga Newsdesk
-
Apr 8, 2024, 8:14AM
Friday, March 22, 2024
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
-
Mar 22, 2024, 5:33PM
Wednesday, March 20, 2024
Psyched: LSD, Psilocybin As Breakthrough Therapies, $14M Fed Grant For Ibogaine, Indiana's Research And More
Lara Goldstein
-
Mar 20, 2024, 2:49PM
Monday, March 18, 2024
Psyence Biomedical Welcomes Results Of A Recent Study Highlighting Benefits Of Nature Derived Psilocybin Vs. Synthetic Psilocybin
Benzinga Newsdesk
-
Mar 18, 2024, 4:11PM
Friday, March 15, 2024
Psyence Biomedical Ltd. Receives Nasdaq Notifications Regarding Market Value Of Listed Securities And Market Value Of Publicly Held Shares
Benzinga Newsdesk
-
Mar 15, 2024, 4:33PM
Why Jabil Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor
-
Mar 15, 2024, 2:31PM
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
-
Mar 15, 2024, 1:31PM
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
-
Mar 15, 2024, 9:06AM
Why Cardlytics Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
-
Mar 15, 2024, 8:13AM
Thursday, March 14, 2024
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
-
Mar 14, 2024, 1:31PM
Psyence Biomedical shares are trading higher after the Indiana legislature sent a bill that includes funding for psilocybin clinical research trials to the governor.
Benzinga Newsdesk
-
Mar 14, 2024, 12:46PM
Reported Earlier, 'Indiana Lawmakers Send Psilocybin Research Funding Bill To Governor' - Marijuana Moment
Benzinga Newsdesk
-
Mar 14, 2024, 12:42PM
Wednesday, March 13, 2024
Why Clover Health Investments Shares Are Trading Higher By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
-
Mar 13, 2024, 1:18PM
Tuesday, March 12, 2024
Why Asana Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
-
Mar 12, 2024, 2:07PM
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
-
Mar 12, 2024, 1:31PM
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
-
Mar 12, 2024, 9:05AM
Monday, March 11, 2024
Psyence Biomedical Will Undertake Psilocybin Clinical Trials For Palliative Care In Australia
Lara Goldstein
-
Mar 11, 2024, 7:02PM
Why Mesoblast Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
-
Mar 11, 2024, 1:41PM
Why Fangdd Network Group Shares Are Trading Higher By Around 78%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
-
Mar 11, 2024, 8:08AM
Friday, March 08, 2024
Why Marvell Technology Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor
-
Mar 8, 2024, 1:47PM
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
-
Mar 8, 2024, 12:31PM
What's Going On With Psyence Biomedical Stock?
Erica Kollmann
-
Mar 8, 2024, 12:15PM
Nasdaq Gains Over 50 Points; US Economy Adds 275,000 Jobs In February
Avi Kapoor
-
Mar 8, 2024, 9:42AM
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
-
Mar 8, 2024, 8:09AM
Thursday, March 07, 2024
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
-
Mar 7, 2024, 12:31PM
Wednesday, March 06, 2024
Psyence Biomedical shares are trading higher after the company announced its subsidiary, Psyence Australia, received Human Research Ethics Committee approval to initiate its Phase IIb study.
Benzinga Newsdesk
-
Mar 6, 2024, 1:55PM
Why CrowdStrike Shares Are Trading Higher By Around 24%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
-
Mar 6, 2024, 8:14AM
Psyence Biomedical's Subsidiary, Psyence Australia, Receives Human Research Ethics Committee (HREC) Approval To Initiate Phase IIb Study
Benzinga Newsdesk
-
Mar 6, 2024, 7:05AM
Wednesday, February 07, 2024
Why Fortinet Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
-
Feb 7, 2024, 7:55AM
Monday, January 29, 2024
Why Panbela Therapeutics Shares Are Trading Lower By 65%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
-
Jan 29, 2024, 2:09PM
Tuesday, June 13, 2017
Quest Diagnostics to Buy 2 Labs, Grow in Oncology Space
Benzinga
-
Jun 13, 2017, 8:30AM
Wednesday, March 19, 2014
Pacific Booker Spokesperson Attributes Earlier Spike in Share Price to News Release of March 12 Being Circulated
Benzinga
-
Mar 19, 2014, 12:44PM
Seeing Another Circuit Breaker in Pacific Booker Minerals, Stock Now Up Just 6.7%
Benzinga
-
Mar 19, 2014, 11:11AM
Pacific Booker Minerals Halted on Volatility Trading Pause, Shares Up 10.5%
Benzinga
-
Mar 19, 2014, 11:01AM
Tuesday, December 10, 2013
Morning Market Movers
Benzinga
-
Dec 10, 2013, 9:54AM
Wednesday, October 10, 2012
Morning Market Movers
Benzinga
-
Oct 10, 2012, 9:47AM
Tuesday, October 02, 2012
Morning Market Losers
Benzinga
-
Oct 2, 2012, 10:16AM
Wednesday, April 18, 2012
SXC and Catalyst to Combine; $13 Billion Combined Company
Benzinga
-
Apr 18, 2012, 6:30AM
Tuesday, December 20, 2011
Deutsche Bank Reports CVS Caremark's Expected EPS Range Ahead of Analyst Day
Benzinga
-
Dec 20, 2011, 8:55AM
Thursday, October 20, 2011
Express Scripts Earnings Preview: Analysts Expect Higher EPS, Revenue
Benzinga
-
Oct 20, 2011, 3:02PM
Friday, July 22, 2011
Earnings Preview: Express Scripts EPS, Revenue Expected to Rise from Previous Quarter
Benzinga
-
Jul 22, 2011, 1:11PM
Monday, July 18, 2011
Morning Market Movers
Benzinga
-
Jul 18, 2011, 9:56AM
Tuesday, June 28, 2011
Oppenheimer Outperform On Amgen
Benzinga
-
Jun 28, 2011, 8:18AM
Friday, May 06, 2011
Top Software and Programming Stock Picks on 5/6/11- BMC, ERTS, VRNG, VELT, IGTE, CRYP, SXCI, ADAT, FTNT, CYDE, PAR, AZPN, CCGM, MGT
Benzinga
-
May 6, 2011, 5:11AM
Monday, April 25, 2011
Express Scripts Earnings Preview (ESRX)
Benzinga
-
Apr 25, 2011, 3:13PM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch